FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tatsuya Kawaguchi

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Flow Cytometry

Living Beings

Co-author Network

Publications

TOP 3
Tatsuya Kawaguchi
[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 2. Paroxysmal nocturnal hemoglobinuria].
Misato Yuki; Takashi Uchida; Yuji Yamakawa; Akinobu Hamada; Tatsuya Kawaguchi; Takeru Nambu; Hideyuki Saito
High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Takeru Nambu; Akinobu Hamada; Reiko Nakashima; Misato Yuki; Tatsuya Kawaguchi; Hiroaki Mitsuya; Hideyuki Saito
Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tatsuya Kawaguchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tatsuya Kawaguchi
[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 2. Paroxysmal nocturnal hemoglobinuria].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2012;101(7):1891-7.
2011: Misato Yuki; Takashi Uchida; Yuji Yamakawa; Akinobu Hamada; Tatsuya Kawaguchi; Takeru Nambu; Hideyuki Saito
High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Biological & pharmaceutical bulletin 2011;34(7):1126-8.
2011: Takeru Nambu; Akinobu Hamada; Reiko Nakashima; Misato Yuki; Tatsuya Kawaguchi; Hiroaki Mitsuya; Hideyuki Saito
Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.
Biological & pharmaceutical bulletin 2011;34(1):114-9.
2010: Rie Yamada; Kentaro Horikawa; Sonoko Ishihara; Koyu Hoshino; Tatsuya Kawaguchi; Ken-ichi Iyama; Hiroaki Mitsuya; Norio Asou
Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug.
International journal of hematology 2010;91(4):711-5.
2009: Tatsuya Kawaguchi; Akinobu Hamada; Chie Hirayama; Reiko Nakashima; Takeru Nambu; Yuji Yamakawa; Hiroshi Watanabe; Kentaro Horikawa; Hiroaki Mitsuya; Hideyuki Saito
Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia.
International journal of hematology 2009;89(5):642-8.
2008: Kentaro Horikawa; Hironori Kudo; Sonoko Ishihara; Toshikazu Miyakawa; Tatsuya Kawaguchi; Hiroaki Mitsuya
[Aspergillosis of masticator space including mandibular bone responding to itraconazole treatment in a diabetic adult: case report].
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases 2008;82(3):220-3.
2007: Tatsuya Kawaguchi; Hideki Nakakuma
New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
International journal of hematology 2007;86(1):27-32.
2006: Nobuyoshi Hanaoka; Tatsuya Kawaguchi; Kentaro Horikawa; Shoichi Nagakura; Hiroaki Mitsuya; Hideki Nakakuma
Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
Blood 2006;107(3):1184-91.
2003: Hideki Nakakuma; Tatsuya Kawaguchi
Pathogenesis of selective expansion of PNH clones.
International journal of hematology 2003;77(2):121-4.
2002: Shoichi Nagakura; Sonoko Ishihara; Daniel E Dunn; Jun-ichi Nishimura; Tatsuya Kawaguchi; Kentaro Horikawa; Michihiro Hidaka; Tadashi Kagimoto; Nozomu Eto; Hiroaki Mitsuya; Taroh Kinoshita; Neal S Young; Hideki Nakakuma
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro.
Blood 2002;100(3):1031-7.
2002: Kentaro Horikawa; Tatsuya Kawaguchi; Sonoko Ishihara; Shoichi Nagakura; Michihiro Hidaka; Tadashi Kagimoto; Hiroaki Mitsuya; Hideki Nakakuma
Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria.
Blood 2002;99(1):24-9.
2000: Sonoko Ishihara; Hideki Nakakuma; Tatsuya Kawaguchi; Shoichi Nagakura; Kentaro Horikawa; Michihiro Hidaka; Norio Asou; Hiroaki Mitsuya
Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
International journal of hematology 2000;72(2):206-9.
2000: K Li; Tatsuya Kawaguchi; Sonoko Ishihara; Kentaro Horikawa; Michihiro Hidaka; M Sakaguchi; R Tsuruzaki; M Kawakita; Tadashi Kagimoto; Hiroaki Mitsuya; Hideki Nakakuma
Rarity of microsatellite alterations in patients with paroxysmal nocturnal haemoglobinuria.
European journal of haematology 2000;64(6):430-2.
2000: Sonoko Ishihara; Kentaro Horikawa; Tatsuya Kawaguchi; L Ke; Michihiro Hidaka; Shoichi Nagakura; Hiroaki Mitsuya; F Sendo; Hideki Nakakuma
3H9, a monoclonal antibody capable of discriminating neutrophilic from basophilic and eosinophilic granulocytes.
European journal of haematology 2000;64(4):275-6.
2000: Tatsuya Kawaguchi; S Koga; H Hongo; Y Komiyama; K Li; Sonoko Ishihara; Kentaro Horikawa; Michihiro Hidaka; Hiroaki Mitsuya; Hideki Nakakuma
A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription.
International journal of hematology 2000;71(1):84-9.
1997: Hideki Nakakuma; Shoichi Nagakura; Tatsuya Kawaguchi; Kentaro Horikawa; N Iwamoto; Tadashi Kagimoto; Kiyoshi Takatsuki
Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria.
International journal of hematology 1997;66(4):451-7.
1997: Kentaro Horikawa; Hideki Nakakuma; Tatsuya Kawaguchi; N Iwamoto; Shoichi Nagakura; Tadashi Kagimoto; Kiyoshi Takatsuki
Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
Blood 1997;90(7):2716-22.
1997: Shoichi Nagakura; Tatsuya Kawaguchi; K Fujimoto; Kentaro Horikawa; N Iwamoto; Hideki Nakakuma
Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia.
International journal of hematology 1997;65(2):187-9.
1996: Hideki Nakakuma; Tatsuya Kawaguchi
Paroxysmal nocturnal hemoglobinuria (PNH): mechanism of intravascular hemolysis.
Critical reviews in oncology/hematology 1996;24(3):213-29.
1996: Tatsuya Kawaguchi; Hideki Nakakuma
[Glycosylphosphatidylinositol-anchored proteins with complement-regulatory activity on erythrocytes].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(9):2370-5.
1996: N Iwamoto; Tatsuya Kawaguchi; Kentaro Horikawa; Shoichi Nagakura; Tadashi Kagimoto; Toshio Suda; Kiyoshi Takatsuki; Hideki Nakakuma
Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice.
Blood 1996;87(12):4944-8.
1995: Hideki Nakakuma; M Hidaka; Shoichi Nagakura; Y Nishimura; N Iwamoto; Kentaro Horikawa; Tatsuya Kawaguchi; Tadashi Kagimoto; Kiyoshi Takatsuki
Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
The Journal of clinical investigation 1995;96(1):201-6.
1995: N Iwamoto; Tatsuya Kawaguchi; Shoichi Nagakura; M Hidaka; Kentaro Horikawa; Tadashi Kagimoto; Kiyoshi Takatsuki; Hideki Nakakuma
Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Blood 1995;85(8):2228-32.
1995: Hideki Nakakuma; Shoichi Nagakura; N Iwamoto; Tatsuya Kawaguchi; M Hidaka; Kentaro Horikawa; Tadashi Kagimoto; T Shido; Kiyoshi Takatsuki
Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia.
Blood 1995;85(5):1371-6.
1995: S Mori; Hitoshi Suzushima; K Nishikawa; H Miyake; Y Yonemura; N Tsuji; Tatsuya Kawaguchi; Norio Asou; Makoto Kawakita; Kiyoshi Takatsuki
Smoldering gamma delta T-cell granular lymphocytic leukemia associated with pure red cell aplasia.
Acta haematologica 1995;94(1):32-5.
1994: Hideki Nakakuma; Shoichi Nagakura; Tatsuya Kawaguchi; N Iwamoto; M Hidaka; Kentaro Horikawa; Tadashi Kagimoto; R Tsuruzaki; Kiyoshi Takatsuki
Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria.
Blood 1994;84(11):3925-8.
1994: E Nakahashi; N Kuribayashi; N Tsuji; Tatsuya Kawaguchi; Hiroyuki Hata; Hiromitsu Matsuzaki; K Shimizu; Kiyoshi Takatsuki
[Primary plasma cell leukemia complicated with high-output cardiac failure and hyperammonemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1994;35(8):756-60.
1994: Hideki Nakakuma; Shoichi Nagakura; Kentaro Horikawa; M Hidaka; Tatsuya Kawaguchi; N Iwamoto; Isao Sanada; Tadashi Kagimoto; Kiyoshi Takatsuki
Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.
Blood 1994;84(1):309-14.
1994: M Kozawa; Hiroyuki Hata; Tatsuya Kawaguchi; N Tsuji; S Mori; N Harada; E Nakahashi; K Sakata; Hiromitsu Matsuzaki; Kiyoshi Takatsuki
[Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1994;35(1):49-53.
1993: M Hidaka; Shoichi Nagakura; Kentaro Horikawa; Tatsuya Kawaguchi; N Iwamoto; Tadashi Kagimoto; Kiyoshi Takatsuki; Hideki Nakakuma
Impaired glycosylation of glycosylphosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leucocytes.
Biochemical and biophysical research communications 1993;191(2):571-9.
1992: Hideki Nakakuma; Kentaro Horikawa; Tatsuya Kawaguchi; M Hidaka; Shoichi Nagakura; S Hirai; Toshiro Kageshita; Tomomichi Ono; Tadashi Kagimoto; M Iwamori
Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Japanese journal of clinical oncology 1992;22(5):308-12.
1992: M Hidaka; Hideki Nakakuma; Tatsuya Kawaguchi; Shoichi Nagakura; Kentaro Horikawa; Y Okuno; Tadashi Kagimoto; Kiyoshi Takatsuki
Altered expression of protein kinase C in adult T-cell leukemia cells.
International journal of hematology 1992;56(2):135-41.
1992: Hideki Nakakuma; Shoichi Nagakura; Tatsuya Kawaguchi; Kentaro Horikawa; Tadashi Kagimoto; Makoto Kawakita; M Tomita; Kiyoshi Takatsuki
Increased plasma decay-accelerating factor levels in paroxysmal nocturnal hemoglobinuria.
International journal of hematology 1992;55(2):121-5.
1992: A Kimoto; T Konno; Tatsuya Kawaguchi; Y Miyauchi; Hiroshi Maeda
Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
Cancer research 1992;52(4):1013-7.
1991: Hideki Nakakuma; Tatsuya Kawaguchi
[Altered metabolism of membrane glycosphingolipids in erythrocytes of paroxysmal nocturnal hemoglobinuria].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1991;32(6):606-11.
1991: Tadashi Kagimoto; T Oda; Hideki Nakakuma; Tatsuya Kawaguchi; M Hidaka; Kentaro Horikawa; Hiromitsu Matsuzaki; Kiyoshi Takatsuki
[Serum deoxythymidine kinase activity in adult T-cell leukemia].
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(1):63-7.
1990: Hideki Nakakuma; Tatsuya Kawaguchi; Kiyoshi Takatsuki
[Ganglioside as a potential immune modulator: selective CD4-modulation and inhibition of human immunodeficiency virus infection].
Seikagaku. The Journal of Japanese Biochemical Society 1990;62(8):1044-7.
1990: Hideki Nakakuma; Tatsuya Kawaguchi; Kentaro Horikawa; M Hidaka; Y Yonemura; Makoto Kawakita; Tadashi Kagimoto; M Iwamori; Y Nagai; Kiyoshi Takatsuki
Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria.
The Journal of clinical investigation 1990;85(5):1456-61.
1990: Y Yonemura; Makoto Kawakita; A Koito; Tatsuya Kawaguchi; Hideki Nakakuma; Tadashi Kagimoto; T Schichishima; T Terasawa; Y Akagaki; S Inai
Paroxysmal nocturnal haemoglobinuria with coexisting deficiency of the ninth component of complement: lack of massive haemolytic attack.
British journal of haematology 1990;74(1):108-13.
1989: Hideki Nakakuma; Tatsuya Kawaguchi; A Koito; T Hattori; Tadashi Kagimoto; Kiyoshi Takatsuki
Inhibition of human immunodeficiency virus infection of human lymphocytes by gangliosides.
Japanese journal of cancer research : Gann 1989;80(8):702-5.
1989: Hideki Nakakuma; Tatsuya Kawaguchi; Kiyoshi Takatsuki
[Glycosphingolipids affect on the functional properties of human lymphocytes--in relation to HIV-infection of lymphocytes].
Human cell 1989;2(1):45-50.
1989: Tatsuya Kawaguchi; Hideki Nakakuma; Tadashi Kagimoto; K Shirono; Kentaro Horikawa; M Hidaka; M Iwamori; Y Nagai; Kiyoshi Takatsuki
Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes.
Biochemical and biophysical research communications 1989;158(3):1050-9.